Murthy Prithvi B, Bryk Darren J, Lee Byron H, Haber Georges-Pascal
Department of Urology, Glickman Urological & Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
Transl Androl Urol. 2020 Apr;9(2):942-948. doi: 10.21037/tau.2019.11.36.
Robotic assisted radical cystectomy (RARC) has gained popularity within minimally-invasive urologic surgery, and has been shown to be a safe procedure with similar oncologic outcomes when compared to the conventional open standard. While initial RARC feasibility and outcomes studies were performed with extracorporeal urinary diversion, intracorporeal urinary diversion (ICUD) is becoming increasingly utilized. Reported benefits of an intracorporeal approach include decreased blood loss and a lower incidence of ureteral strictures. While ICUD is technically challenging, many have overcome the learning curve associated with this procedure via a mentorship model and a dedicated operative team. Techniques vary between institutions, and ileal conduit, continent cutaneous and orthotopic continent (neobladder) diversions have all been performed. Herein, we describe the learning curve, technical points, and unique complications associated with ICUD.
机器人辅助根治性膀胱切除术(RARC)在微创泌尿外科手术中越来越受欢迎,并且已被证明是一种安全的手术,与传统开放标准相比,其肿瘤学结局相似。虽然最初的RARC可行性和结局研究是采用体外尿液改道进行的,但体内尿液改道(ICUD)的应用越来越多。体内手术方式的已知益处包括减少失血和输尿管狭窄发生率较低。虽然ICUD在技术上具有挑战性,但许多人通过导师指导模式和专业的手术团队克服了与该手术相关的学习曲线。各机构的技术有所不同,回肠导管、可控性皮肤造口和原位可控性(新膀胱)改道均已实施。在此,我们描述与ICUD相关的学习曲线、技术要点和独特并发症。